The Latest

Michigan state flag

A Plan to End Hepatitis C in Michigan Through Harm Reduction and Compassionate Care

Ranked as 7th in the nation for HCV prevalence, Michigan launches an initiative to expand testing, treatment, and assistance and reduce stigma.

By Juan Michael Porter II
David Alain Wohl recaps CROI 2021 research during a video interview

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

Sleep and Diet: Don’t Underestimate Their Importance for People Living With HIV

David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021

Hypertension Control Emerges as Key Concern in Examination of HIV, Aging, and Cardiovascular Disease

David Alain Wohl, M.D., talks through new data presented at CROI 2021 that further our understanding of the interplay between HIV and comorbidities we often associate with aging, particularly those related to cardiovascular disease.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps COVID-19 research from CROI 2021

HIV & COVID-19: CROI 2021 Reveals New Research

David Alain Wohl, M.D., analyzes updated data regarding the intersection of HIV and COVID-19, with a particular focus on SARS-CoV-2 susceptibility and disease severity.

By David Alain Wohl, M.D.
triptych of medical scientists performing lab and research duties

Top 10 HIV Clinical Developments of 2020

In this exclusive series of articles, David Alain Wohl, M.D., calls attention to 10 developments that have tremendous short-term implications for our day-to-day efforts to improve HIV prevention, treatment, patient care, and policy in the U.S., and analyzes each development with his trademark wit and clinical savvy.

By David Alain Wohl, M.D.
COVID-19 mask

HIV in the Time of COVID-19

While we remain uncertain about the precise level of interaction (if any) between HIV and SARS-CoV-2 on a pathophysiological level, the pandemic’s disruption of HIV care is irrefutable.

By David Alain Wohl, M.D.
health care

Mortality Is Way Down Among People With HIV in the U.S.

A new report from the CDC highlights encouraging trends in death rates among people with HIV in the U.S., and is explicit in associating them with strong and concerted public health interventions.

By David Alain Wohl, M.D.

What Drives Lower Life Expectancy for People With HIV in the U.S.?

Given the decline in mortality among people living with HIV in the U.S., it’s no surprise that the difference in life expectancy between those with and without the virus is shrinking. But the disparities that remain are striking.

By David Alain Wohl, M.D.
weight gain

Why Is Weight Gain Occurring Among Some People Who Start HIV Treatment?

Given the differences we’ve seen among disparate subgroups, it is highly likely that there are genetic influences on the amount of weight people gain on certain HIV therapies, argues David Wohl, M.D.

By David Alain Wohl, M.D.